Connect with us
As vaccine sales for Novavax, Moderna, and BioNTech shift in line with a changing Covid-19 situation, the results are being felt in the stock markets. Here...
Gilead's peak revenue in Spain was in 2015 when the company had a turnover $1.15 billion (€978.5 million). Those figures were due to the commercialization of...
The most sensational news came, on December 7th, from the Tübingen headquarters of Curevac, when its CEO Franz-Werner Haas announced the upcoming application for approval of...
BioNTech CEO Sierk Pötting expects to be able to present the first data from the ongoing study on the efficacy of BNT162 at the end of...
Biotech companies around the world have entered the race to find a coronavirus vaccine. In view of the increasingly critical situation of the coronavirus pandemic, the...
The Mainz-based biotech company BioNTech has recently presented the results of the capital increase. The company is developing a COVID-19 vaccine together with Pfizer, already in...
The recent COVID-19 pandemic has brought together several biotech companies from around the world in an unprecedented effort to find a COVID-19 vaccine that would save...